Browse our anti-TNFRSF13C (TNFRSF13C) Antibodies

Full name:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 13C Antibodies (TNFRSF13C)
On are 218 Tumor Necrosis Factor Receptor Superfamily, Member 13C (TNFRSF13C) Antibodies from 28 different suppliers available. Additionally we are shipping TNFRSF13C Kits (44) and TNFRSF13C Proteins (36) and many more products for this protein. A total of 315 TNFRSF13C products are currently listed.
2010006P15Rik, BAFF-R, Baffr, Bcmd, Bcmd-1, Bcmd1, BROMIX, CD268, CVID4, Lvis22, prolixin, RGD1560810, TNFRSF13C
list all antibodies Gene Name GeneID UniProt
TNFRSF13C 500910  
TNFRSF13C 115650 Q96RJ3
TNFRSF13C 72049 Q9D8D0

Show all species

Show all synonyms

Most Popular Reactivities for anti-TNFRSF13C (TNFRSF13C) Antibodies

Select your species and application

anti-Rat (Rattus) TNFRSF13C Antibodies:

anti-Human TNFRSF13C Antibodies:

anti-Mouse (Murine) TNFRSF13C Antibodies:

All available anti-TNFRSF13C Antibodies

Go to our pre-filtered search.

Top referenced anti-TNFRSF13C Antibodies

  1. Mouse (Murine) Monoclonal TNFRSF13C Primary Antibody for FACS - ABIN4899448 : Benson, Dillon, Castigli, Geha, Xu, Lam, Noelle: Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)
    Show all 3 references for 4899448

  2. Human Monoclonal TNFRSF13C Primary Antibody for - ABIN1449228 : Waldmann: The meandering 45-year odyssey of a clinical immunologist. in Annual review of immunology 2003 (PubMed)
    Show all 2 references for 1449228

  3. Human Monoclonal TNFRSF13C Primary Antibody for FACS - ABIN2853608 : Nakamura, Hase, Sakurai, Yoshida, Abe, Tsukada, Takizawa, Aoki, Kojima, Nakamura, Kobata: Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody. in Virchows Archiv : an international journal of pathology 2005 (PubMed)
    Show all 2 references for 2853608

  4. Mouse (Murine) Monoclonal TNFRSF13C Primary Antibody for FACS - ABIN4896128 : Patke, Mecklenbräuker, Erdjument-Bromage, Tempst, Tarakhovsky: BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. in The Journal of experimental medicine 2006 (PubMed)

  5. Mouse (Murine) Monoclonal TNFRSF13C Primary Antibody for CyTOF, ELISA - ABIN4282888 : Ma, Zhang, Liu, Wang, Liu, Zhu, Yu, Han, Chen, Hou, Wang, Ma, Shen, Li, Xiao, Wang: B cell activating factor (BAFF) selects IL-10(-)B cells over IL-10(+)B cells during inflammatory responses. in Molecular immunology 2017 (PubMed)

More Antibodies against TNFRSF13C Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 13C (TNFRSF13C) interaction partners

  1. The expression levels of serum BAFF (show TNFSF13B Antibodies) and the three receptors (TACI (show TNFRSF13B Antibodies), BCMA (show TNFRSF17 Antibodies) and BAFF-R) in non-Hodgkin lymphoma patients were significantly higher than in healthy controls.

  2. Variants in BAFF-R gene is associated with chronic lymphocytic leukemia.

  3. BAFF-R, as the principal receptor of BAFF (show TNFSF13B Antibodies), not only decreased the apoptosis of B cells and CD8 (show CD8A Antibodies)+ T cells by upregulating the expression of Bcl-2 (show BCL2 Antibodies) and BclxL (show BCL2L1 Antibodies), but also promoted B-cell proliferation in immune thrombocytopenia.

  4. BAFF (show TNFSF13B Antibodies) and BAFF-R are expressed in the thyrocytes derived from patients with either autoimmune thyroid disorders or multinodular goiter, as well in the infiltrating immune cells of Graves' disease and Hashimoto's thyroiditis

  5. There is an increased prevalence of the BAFF-R His159Tyr mutation in patients with Sjogren's syndrome (SS), particularly in those with SS complicated by MALT lymphoma whose disease onset occurred at a younger age.

  6. Expression of mutant caspase-9 (show CASP9 Antibodies) correlated with a downregulation of BAFFR (B-cell-activating factor (show TNFSF13B Antibodies) belonging to the TNF (show TNF Antibodies) family (BAFF) receptor) in B cells and ICOS (inducible T-cell costimulator (show ICOS Antibodies)) in T cells.

  7. Variants of TNFRSF13C were associated with common variable immunodeficiency.

  8. Negative expression of BAFF-R, but not of BAFF (show TNFSF13B Antibodies), could be an independent risk factor for progression-free survival and Overall survival in patients with diffuse large B-cell lymphoma treated with standard R-CHOP (show DDIT3 Antibodies).

  9. the common TLR4 (show TLR4 Antibodies)-D299G, TLR4 (show TLR4 Antibodies)-T399I and BAFFR-P21R polymorphisms provide the carriers with a protective advantage against ICU-acquired sepsis; this finding was more profound for medical patients compared to trauma or surgical ones

  10. Data show significant differences in expression of tumour necrosis factor (show TNF Antibodies) family (BAFF (show TNFSF13B Antibodies)) receptors BAFF-R, BCMA (show TNFRSF17 Antibodies) and TACI (show TNFRSF13B Antibodies) in patients with and without anti-Jo-1 or anti-Ro52 (show TRIM21 Antibodies)/anti-Ro60 (show TROVE2 Antibodies) autoantibodies.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 13C (TNFRSF13C) interaction partners

  1. B cell-activating factor (BAFF (show TNFSF13B Antibodies)) upregulates CD28 (show CD28 Antibodies)/B7 and CD40 (show CD40 Antibodies)/CD154 (show CD40LG Antibodies) expression, and promotes the interactions between T and B cells in a BAFF receptor-dependent manner.

  2. conclude that P44S BAFFR mutation does not hinder BAFFR function or enhance B cell activity in MRL/Lpr (show FAS Antibodies) and MRL mice and that other susceptibility loci on the MRL background contributed to the hyperactivity of these cells

  3. Results from this study suggest blockade of CXCL13 (show CXCL13 Antibodies) and BAFFR together may be an effective therapeutic strategy in preventing salivary hypofunction and reducing autoantibody titers and sialadenitis in patients with Sjogren's syndrome

  4. Heteromers consisting of one BAFF (show TNFSF13B Antibodies) and two APRIL bind to receptor TACI (show TNFRSF13B Antibodies), BCMA (show TNFRSF17 Antibodies) but not to BAFFR.

  5. Syk (show SYK Antibodies)-deficient B cells require BAFF receptor and CD19 (show CD19 Antibodies)/PI3K signaling for their long-term survival.

  6. In conclusion, BAFFR signaling affects both innate and adaptive immune activation during viral infections.

  7. BAFF (show TNFSF13B Antibodies) controls neural cell survival through BAFF receptor.

  8. BAFF receptor deficiency limits Murid herpesvirus 4 infection.

  9. Although we have found that TACI is dispensable for controlling B. hermsii infection, mice deficient in BAFFR or BAFF exhibit impairment in B. hermsii-specific IgM responses and clearance of bacteremia.

  10. tnfrsf13c is dispensable for the development of SLE in NZM mice.

TNFRSF13C Antigen Profile

Antigen Summary

B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of Baff in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells. The protein encoded by this gene is a receptor for BAFF and is a type III transmembrane protein containing a single extracellular cysteine-rich domain. It is thought that this receptor is the principal receptor required for BAFF-mediated mature B-cell survival.

Alternative names and synonyms associated with TNFRSF13C

  • tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C) antibody
  • tumor necrosis factor receptor superfamily, member 13c (Tnfrsf13c) antibody
  • tumor necrosis factor receptor superfamily member 13C-like (LOC618516) antibody
  • 2010006P15Rik antibody
  • BAFF-R antibody
  • Baffr antibody
  • Bcmd antibody
  • Bcmd-1 antibody
  • Bcmd1 antibody
  • BROMIX antibody
  • CD268 antibody
  • CVID4 antibody
  • Lvis22 antibody
  • prolixin antibody
  • RGD1560810 antibody
  • TNFRSF13C antibody

Protein level used designations for TNFRSF13C

tumor necrosis factor receptor superfamily, member 13C , tumor necrosis factor receptor superfamily member 13C , B cell-activating factor receptor , B-cell-activating factor receptor , BAFF receptor , BLyS receptor 3 , B-cell maturation defect 1 , b cell-activating factor receptor

417983 Gallus gallus
500910 Rattus norvegicus
607785 Canis lupus familiaris
618516 Bos taurus
746611 Pan troglodytes
115650 Homo sapiens
72049 Mus musculus
Selected quality suppliers for anti-TNFRSF13C (TNFRSF13C) Antibodies
Did you look for something else?